drugset / Trial / NCT00003259
Vinorelbine in Treating Patients With Metastatic Prostate Cancer
Treatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of vinorelbine in treating patients with metastatic prostate cancer that has not responded to hormone therapy.
Timeline
- Start
- 1997-10
- Primary completion
- 1999-09
- Completion
- 1999-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vinorelbine | Small molecule | 30 mg/m2 | Intravenous |